Table 5.
Phase 1 | Phase 2 | |
---|---|---|
Hospital (Outcome known) (n) | 383 | 309 |
Expected Mortality (mean%) | 34 | 34 |
Expected Deaths (n) | 130 | 105 |
Observed deaths (n) | 118 | 72 |
Observed mortality (mean%) | 31 | 23 |
OE ratio | 0,91 | 0,69 |
Unexpected survivors (n) | 12 | 33 |
6 month total (Outcome known) (n) | 229 | 286 |
Expected Unfavorable (mean%) | 60,3 | 54 |
Expected Unfavorable (n) | 138 | 154 |
Observed Unfavorable (n) | 154 | 105 |
Observed Unfavorable (mean%) | 67 | 37 |
OE ratio | 1,12 | 0,68 |
Unexpected favorable (n) | -16 | 49 |
Legend: OE observed/expected; 6 month outcome was measured by GOSE (Glasgow Outcome Scale extended) and dichotomized into favorable (GOSE score 7–8) and unfavorable (GOSE score 1–6) outcomes, OE Observed versus Expected